Startup develops late-stage prostate cancer therapy that could increase patient survival rates
A biomedical startup that licensed a Purdue University technology has developed a late-stage prostate cancer therapy that could provide an alternative to current hormone therapies that are known to develop resistance after ...
Oct 13, 2016
0
9